BioLineRx Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Modi In
SEC filing record 1 source field available
Fiscal year end
31 December
BioLineRx Ltd. has filed 604 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 201-225 of 604 matching filings.

Per page
25
Current page
9
6-K File 001-35223

6-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
25 Sep 2019
Reporting date
25 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
03 Sep 2019
Reporting date
03 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 001-35223

20-F/A

Filing date
30 Jul 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
02 Jul 2019
Reporting date
02 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
28 Jun 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 001-35223

20-F/A

Filing date
05 Jun 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
28 May 2019
Reporting date
28 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
20 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
14 May 2019
Reporting date
14 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
07 May 2019
Reporting date
07 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
28 Mar 2019
Reporting date
28 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
27 Mar 2019
Reporting date
27 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35223

CT ORDER filing

Filing date
21 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86614

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
01 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-229021

EFFECT filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86614

BIOLINERX LTD.

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86614

BIOLINERX LTD.

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35223

6-K

Filing date
07 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .